Conantokin G (free acid)

CAS No. 133628-78-1

Conantokin G (free acid)( ——— )

Catalog No. M39889 CAS No. 133628-78-1

Conantokin G (free acid)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote

Biological Information

  • Product Name
    Conantokin G (free acid)
  • Note
    Research use only, not for human use.
  • Brief Description
    Conantokin G (free acid)
  • Description
    Conantokin G (free acid)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    133628-78-1
  • Formula Weight
    2265.16
  • Molecular Formula
    C88H137N25O45
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 3-Phenyl-2-propen-1-...

    The compounds 3-phenyl-2-propen-1-ol , 2-methyl-3-butyn-2-ol, 3,7-dimethylnonane, and 2-hydroxybenzoic acid occurred only during estrus which may be considered as marker for detection of estrus which would ultimately help for artificial insemination in captive condition.

  • Propiconazole

    Propiconazole (Standard) is the analytical standard of Propiconazole. This product is intended for research and analytical applications. Propiconazole is an orally active N-substituted triazole used as a fungicide. Propiconazole is a mouse liver hepatotoxicant and a hepatocarcinogen that has adverse reproductive and developmental toxicities in experimental animals.

  • Quazolast

    Quazolast (RHC 3988) is a potent mediator release inhibitor used as a control against ragweed antigenic nasal challenge and demonstrates superiority over placebo in preventing nasal congestion and nasal itching following such challenges.